Notice Type
Notice Title

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:


Active Ingredient:
Dosage Form:
New Zealand Sponsor:

Alpha1-Proteinase inhibitor 1000mg
Powder for injection
CSL Behring (NZ) Limited
CSL Behring LLC, Illinois, United States of America

Note: This renewed consent is valid for two years from 24 March 2017.

Dated this 13th day of March 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).